Lipid-lowering drugs (statins), cholesterol, and coenzyme Q(10). The Baycol case - a modern Pandora's box

被引：49

作者：

Bliznakov, EG ^{[1
]}

机构：

[1] Biomed Res Consultants, Pompano Beach, FL 33069 USA

来源：

关键词：

cardiovascular diseases; cholesterol; coenzyme Q(10); HMG-CoA reductase inhibitors; oxidative stress; statins;

D O I：

10.1016/S0753-3322(01)00150-0

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：56 / 59

页数：4

共 18 条

[1] AOKI N, 2001, SAN FRANCISCO C 0604
[2] APPELKVIST EL, 1993, CLIN INVESTIGATOR, V71, pS97
[3] Medical ethics
Bliznakov, EG
[J]. LANCET, 2000, 356 (9240) : 1522 - 1522
[4] Bliznakov EG, 1998, ADV THER, V15, P218
[5] BROWN MS, 1990, Patent No. 4933165
[6] Caliskan S, 2000, RES EXP MED, V199, P189
[7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Cleeman, JI
Grundy, SM
Becker, D
Clark, LT
Cooper, RS
Denke, MA
Howard, WJ
Hunninghake, DB
Illingworth, DR
Luepker, RV
McBride, P
McKenney, JM
Pasternak, RC
Stone, NJ
Van Horn, L
Brewer, HB
Ernst, ND
Gordon, D
Levy, D
Rifkind, B
Rossouw, JE
Savage, P
Haffner, SM
Orloff, DG
Proschan, MA
Schwartz, JS
Sempos, CT
Shero, ST
Murray, EZ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
[8] Low-density lipoprotein-independent effects of statins
Davignon, J
Laaksonen, R
[J]. CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (06) : 543 - 559
[9] Statins and cancer: A case of meta-uncertainty
Guallar, E
Goodman, SN
[J]. AMERICAN JOURNAL OF MEDICINE, 2001, 110 (09) : 738 - 740
[10] Lotronex and the FDA: a fatal erosion of integrity
Horton, R
[J]. LANCET, 2001, 357 (9268) : 1544 - 1545